Comparison between screening for primary aldosteronism with and without drug adjustment

Area of Science:

• Endocrinology
• Hypertension Management
• Diagnostic Accuracy

Background:

• Primary aldosteronism (PA) screening often requires medication adjustments, complicating diagnosis and potentially causing adverse effects.
• Limited data exists on the performance of non-drug-adjusted PA screening protocols.

Purpose of the Study:

• To evaluate the consistency of primary aldosteronism screening results with and without drug adjustment.
• To assess the diagnostic effectiveness of primary aldosteronism screening performed without prior medication changes.

Main Methods:

• A prospective study of 650 hypertensive patients at high risk for PA.
• Comparison of aldosterone-to-renin ratio (ARR) and plasma aldosterone concentration (PAC) with and without drug adjustment.
• Calculation of sensitivity and specificity using confirmatory test results as the gold standard.

Main Results:

• Non-drug-adjusted screening demonstrated high sensitivity (94.7%) and specificity (94.5%) in patients not on combined beta-blockers.
• Overall sensitivity and specificity after drug adjustment were 92.1% and 89%, respectively.
• Screening results were identical with or without drug adjustment in patients not on combined beta-blockers.

Conclusions:

• Non-drug-adjusted primary aldosteronism screening is a reliable and effective method.
• This approach simplifies the diagnostic process and minimizes medication-related complications for patients.
• Clinical importance lies in avoiding unnecessary medication adjustments and potential adverse effects.